摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

苄氧羰基-丁氧基谷氨酸-对硝基苯酯 | 7670-08-8

中文名称
苄氧羰基-丁氧基谷氨酸-对硝基苯酯
中文别名
——
英文名称
(benzyloxycarbonyl)-γ-tert-butyl-L-glutamic acid p-nitrophenyl ester
英文别名
Cbz-Glu(t-Bu)-ONp;Z-Glu(OBut)-ONp;Z-Glu(OtBu)-ONP;N-Benzyloxycarbonyl-L-glutaminsaeure-γ-tert.-butylester-α-(4-nitro-phenylester);Benzyloxycarbonyl-glutaminsaeure-α-(4-nitro-phenylester)-γ-tert.-butylester;Benzyloxycarbonyl-γ-tert.-butyl-L-glutaminsaeure-p-nitrophenylester;5-O-tert-butyl 1-O-(4-nitrophenyl) (2S)-2-(phenylmethoxycarbonylamino)pentanedioate
苄氧羰基-丁氧基谷氨酸-对硝基苯酯化学式
CAS
7670-08-8
化学式
C23H26N2O8
mdl
——
分子量
458.468
InChiKey
QELUBUSZCPJCNC-IBGZPJMESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    33
  • 可旋转键数:
    12
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    137
  • 氢给体数:
    1
  • 氢受体数:
    8

SDS

SDS:4308e97b4e785aae023cec8dbe7f98c4
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • A Synthesis of Human Proinsulin C-Peptide
    作者:Ken’ichi Igano、Yuriko Minotani、Nobuo Yoshida、Masao Kono、Ken Inouye
    DOI:10.1246/bcsj.54.3088
    日期:1981.10
    A peptide corresponding to the thirty-one amino acid sequence of human proinsulin C-peptide (positions 33–63 of proinsulin) was synthesized by the solid-phase method. The product was purified consecutively by gel filtration, DEAE-cellulose chromatography, and high-performance liquid chromatography (HPLC). The purified material behaved as a single component in reversed-phase HPLC, gave correct amino acid ratios, and was not distinguished from natural human C-peptide in terms of immunoreactivity and chromatographic behaviors. The α→β transpeptidation at the Asp-Leu sequence, possible to occur associated with the HF cleavage, was studied using model peptides to demonstrate that the formation of β-peptide was 3–4% regardless of whether the β-carboxylic acid is free or protected as a benzyl ester.
    一段对应于人类前胰岛素C肽(前胰岛素分子中的第33至63位氨基酸序列)的三十一个氨基酸序列的多肽通过固相法被合成。产物依次通过凝胶过滤、DEAE-纤维素色谱法和高性能液相色谱法(HPLC)进行纯化。纯化后的物质在反相HPLC中表现为单一组分,呈现出正确的氨基酸比例,并且在免疫反应性和色谱行为上与天然人C肽无法区分。关于与HF切割相关可能发生的Asp-Leu序列上的α→β转肽反应,通过模型肽的研究表明,无论β-羧酸是自由状态还是被保护为苄酯状态,β-肽的形成率都为3-4%。
  • PEPTIDES WITH CYTOPROTECTIVE ACTIVITY
    申请人:Zamerton Holdings Limited
    公开号:EP2963052A2
    公开(公告)日:2016-01-06
    This invention is related to medicine and concerns peptides with cytoprotective activity selected from a group that includes Ac-Asp-Glu-OH, H-Asp-Glu-OCH3, H-Asp-Glu-NH - CH2-CH3, H-Val-Asp-Glu-OH, H-Leu-Asp- Glu-OH and H-Ala-Asp-Glu-Arg-OH, Ala-Asp-Glu, Lys-Asp-Glu and Asp-Glu-Gly, with the peptides remaining chemically stable in storage. Also proposed is a pharmaceutical composition containing effective quantities of peptides selected from a group that includes Ac-Asp-Glu-OH, H-Asp-Glu-OCH3, H-Asp-Glu-NH - CH2-CH3, H-Val-Asp-Glu-OH, H-Leu-Asp- Glu-OH and H-Ala-Asp-Glu-Arg-OH, Ala-Asp-Glu, Lys-Asp-Glu or Asp-Glu-Gly. The pronounced cytoprotective effect makes it possible to use the pharmaceutical composition in the food, cosmetological and pharmaceutical industries.
    这项发明涉及医学,涉及具有细胞保护活性的肽,所选肽包括Ac-Asp-Glu-OH、H-Asp-Glu-OCH3、H-Asp-Glu-NH-CH2-CH3、H-Val-Asp-Glu-OH、H-Leu-Asp-Glu-OH和H-Ala-Asp-Glu-Arg-OH、Ala-Asp-Glu、Lys-Asp-Glu和Asp-Glu-Gly,这些肽在储存中保持化学稳定。还提出了一种含有所选肽的药物组合物,该组合物包括Ac-Asp-Glu-OH、H-Asp-Glu-OCH3、H-Asp-Glu-NH-CH2-CH3、H-Val-Asp-Glu-OH、H-Leu-Asp-Glu-OH和H-Ala-Asp-Glu-Arg-OH、Ala-Asp-Glu、Lys-Asp-Glu或Asp-Glu-Gly。显著的细胞保护作用使得可以将该药物组合物用于食品、化妆品和制药行业。
  • Development of Potent and Selective Phosphinic Peptide Inhibitors of Angiotensin-Converting Enzyme 2
    作者:Andreas Mores、Magdalini Matziari、Fabrice Beau、Philippe Cuniasse、Athanasios Yiotakis、Vincent Dive
    DOI:10.1021/jm701275z
    日期:2008.4.1
    Arimotensin-converting enzyme 2 (ACE2), a recently identified human homologue of angiotensin-converting enzyme, is a zinc metallocarboxypeptidase which may play a unique role in cardiovascular and renal function. Here we report the discovery of potent and selective inhibitors of ACE2, which have been identified by evaluating a series of phosphinic di- and tripeptides of the general formula: Z-Xaa(PO2-CH2)YaaOH and Ac-Zaa-Xaa(PO2-CH2)YaaOH. The most potent inhibitor in this series is a tripeptide that displays a K-i value of 0.4 nM toward ACE2 and is 3 orders of magnitude less potent toward carboxypeptidase A. Phosphinic tripeptides exhibit high potency exclusively when the Xaa position is occupied by a pseudoproline. A model of interaction between one inhibitor of this series and ACE2 suggests that the critical role played by a proline in inhibitors, but also for substrates hydrolysis, may rely on the presence of Tyr(510) in the ACE2 active site.
  • Synthesis and biological activity of new peptide segments of gastrin exhibiting gastrin antagonist property
    作者:Jean Martinez、Richard Magous、Marie Francoise Lignon、Jeanine Laur、Bertrand Castro、Jean Pierre Bali
    DOI:10.1021/jm00378a012
    日期:1984.12
    A series of C-terminal peptide segments of gastrin, i.e., (tert-butyloxycarbonyl)-L-tryptophyl-L-methionyl-L-aspartic acid amide, (tert-butyloxycarbonyl)-glycyl-L-tryptophyl-L-methionyl-L-aspartic acid amide, (tert-butyloxy-carbonyl)-L-tyrosyl-glycyl-L-tryptophyl-L-methionyl-L-asp artic acid amide, and (benzyloxycarbonyl)-L-glutamyl-L-alanyl-L-tyrosyl-glycyl-L-tryptophyl-L -methionyl-L-aspartic acid amide were prepared and were shown to competitively inhibit the binding of labeled human gastrin to its receptors in an isolated gastric mucosal cell preparation and to antagonize the action of gastrin on gastric acid secretion (ED50 from 1.5 to 7 mg/kg) in vivo in the reperfused rat stomach, determined according to the method of Ghosh and Schild. From these studies, it could be concluded that the C-terminal phenylalanine residue, which is of primary importance for intrinsic biological gastrin-like activity, is not essential for binding to gastrin receptors.
  • Studies on Polypeptides. XXIX. Synthetic Peptides Related to the N-Terminus of Bovine Pancreatic Ribonuclease A (Positions 1-7)<sup>1-4</sup>
    作者:Klaus Hofmann、Ralph Schmiechen、Robert D. Wells、Yecheskel Wolman、Noboru Yanaihara
    DOI:10.1021/ja01081a039
    日期:1965.2
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物